Thirty four years since the discovery of gastrointestinal melatonin

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL.2, 2008, Pages 33-51

  Bubenik, G A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Antioxidant; Digestion; Food intake; Gastrointestinal tract; Melatonin; Motility; Pathologies; Serotonin inhibitor; Therapies

Indexed keywords

HYDROCHLORIC ACID; MELATONIN; SEROTONIN;

ANTIOXIDANT ACTIVITY; CELLULAR DISTRIBUTION; CIRCADIAN RHYTHM; CONFERENCE PAPER; COW; DIGESTION; ENTEROENDOCRINE CELL; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MUCOSA; HEPATOBILIARY SYSTEM; HORMONAL REGULATION; HUMAN; IMMUNOHISTOLOGY; INTESTINE BLOOD FLOW; INTESTINE TRANSIT TIME; NONHUMAN; ONTOGENY; PERISTALSIS; PHYLOGENY; PINEAL BODY; SPECIES DIFFERENCE; SWINE; TISSUE DISTRIBUTION;

ANIMALS; ANTIOXIDANTS; ENERGY INTAKE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MELATONIN;

EID: 51449101022     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (98)

1. Motilva V, Talero E, Calvo JR, Alarcon-de-la Lastra, Sanchez-Fidalgo. Intestinal immuinomodulation. Role of regulatory peptides and promising pharmacological activities. Current Pharmaceut Design 2008; 14: 71-96.
2. Lerner AB, Case LD, Lee TH, Mori V. Isolation of melatonin, the pineal factor that lightens melanocytes. J Am Chem Soc 1958; 80: 2587.
3. Bubenik GA, Uhlir I, Brown GA, Grota LJ. Immunohistological localization of N-acetylindolealkylamines in pineal gland, retina and cerebellum. Brain Res 1973; 81: 233-242.
4. Raikhlin NT, Kvetnoy IM. Lightening effect of the extract of human appendix mucosa on frog skin melanophores. Bull Ext Biol Med 1974; 8: 114-116.
5. Bubenik GA, Brown GM, Grota LJ. Immunohistological localization of melatonin in the rat digestive tract. Experientia 1977; 33: 662-663.
6. Hong GX, Pang SF. N-acetyltransferase activity in the quail (Coturnix coturnix jap) duodenum. Comp Biochem Physiol 1995; 112B: 251-255.
7. Quay WB, Ma YH. Demonstration of gastrointestinal hydroxyindole- O -methyltransferase. IRCS Med Sci 1976; 4: 563.
8. Stefulj J, Hoertner M, Ghosh M et al. Gene expression of the key enzyme of melatonin synthesis in extrapineal tissue of the rat. J Pineal Res 2001; 30: 103-108.
9. Raikhlin NT, Kvetnoy IM. Biological identification of melatonin in enterochromafflne cells. Doklady Akad Nauk USSR 1974; 215: 731-733.
10. Raikhlin NT, Kvetnoy IM, Kadagidze ZG, Sokolov AV. Immunomorphological studies on synthesis of melatonin in enterochromaffine cells. Acta Histochem Cytochem 1978; 11: 75-77.
11. Bubenik GA. Localization of melatonin in the digestive tract of the rat. Effect of maturation, diurnal variation, melatonin treatment and pinealectomy. Horm Res 1980; 12: 313-323.
12. Ozaki Y, Lynch HL. Presence of melatonin in plasma and urine of pinealectomized rats. Endocrinology 1976; 99: 641-644.
13. Vakkuri O, Rintamaki H, Lappaluoto J. Plasma and tissue concentrations after midnight light exposure and pinealectomy in pigeons. J Endocrinol 1985; 105: 263-268.
14. Bubenik GA, Brown GM. Pinealectomy reduces melatonin levels in the serum but not in the gastrointestinal tract of the rat. Biol Signals 1997; 6: 40-44.
15. Bubenik GA, Pang SF, Hacker RR, Smith PS. Melatonin concentration in serum and tissues of porcine gastrointestinal tract and their relationship to the intake and passage of food. J Pineal Res 1996; 21: 251-256.
16. Huether G, Poeggeler G, Reimer R, George A. Effect of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in gastrointestinal tract. Life Sci 1992; 51: 945-953.
17. Bubenik GA, Hacker RR, Brown GM, Bartos L. Melatonin concentration in luminal fluid, mucosa and muscularis of the bovine and porcine gastrointestinal tract. J Pineal Res 1999; 26: 56-63.
18. Chow PH, Lee PPN, Poon AMS, Shiu SYW, Pang SF. The gastrointestinal system: A site of melatonin paracrine action. In: Melatonin: a universal photoperiodic signal with diverse action (Tang PL, Pang SF, Reiter RJ, eds.), Basel Switzerland, Karger, 1997, pp 123-132.
19. Huether G. The contribution of extrapineal sites of melatonin to circulating melatonin levels in higher vertebrates. Experientia 1994; 49: 665-670.
20. Huether G, Messner M, Rodenback A, Hardeland R. Effects of continous infusion on steady state plasma melatonin levels under near physiological conditions. J Pineal Res 1998; 24: 146-151.
21. Quastel R, Rahamimoff R. Effect of melatonin on spontaneous contraction and response to 5-hydroxytryptamine of rat isolated duodenum. Br J Pharmacol 1965; 24: 455-61.
22. Fioretti MC, Menconi E, Ricardi C. Mechanism of the in vitro 5-hydroxytryptamine (5-HT) antagonism exerted by pineal indole derivatives. Riv Farmacol Ter 1974; 5: 43-49.
23. Bubenik GA. The effect of serotonin, N-acetylserotonin and melatonin on spontaneous contraction of isolated rat intestine. J Pineal Res 1986; 3: 41-54.
24. Harlow HJ, Weekly BL. Effect of melatonin on the force of spontaneous contractions of in vitro rat small and large intestine. J Pineal Res 1986; 3: 277-284.
25. 4 and melatonin receptors.Br J Pharmacol 1997; 121: 1775-1781.
26. Bubenik GA, Dhanvantari S. The influence of serotonin and melatonin on some parameters of gastrointestinal activity. J Pineal Res 1989; 7: 333-344.
27. Drago F, Macauda S, Salehi S. Slow doses of melatonin increase intestinal motility in rats. Dig Dis Sci 2000; 47: 1969-1974.
28. Hertz-Eshel M, Rahamimoff. Effect of melatonin on uterine contractility. Life Sci 1965; 4: 1367-1372.
29. Rahamimoff R, Bruderman I, Golshani G. Effect of melatonin on 5-hydroxytryptamine induced contraction of isolated cat trachea. Life Sci 1965; 4: 2281-2287.
30. Viswanathan M, Laitinen JT, Saavendra JM. Expresion of melatonin receptors in arteries involved in thermoregulation. Proc Nat Acad Sci USA 1990; 87: 6200-6203.
31. Cho CH, Pang SF, Chen BW, Pfeiffer CJ. Modulating action of melatonin on serotonin-induced aggravation of ethanol ulceration and changes of mucosal blood flow in rat stomach. J Pineal Res 1989; 6: 89-97.
32. Bubenik GA, Ayles HL, Ball RO, Friendship RM, Brown GM. Relationship between melatonin levels in plasma and gastrointestinal tissues and the incidence and severity of gastric ulcers in pigs. J Pineal Res 1998; 24; 62-66.
33. Pentney P, Bubenik GA. Melatonin reduces the severity of dextran-induced colitis in mice. J Pineal Res 1995; 19: 31-39.
34. Tan D-X, Manchester LC, Lopez-Burillo SL, Mayo JC, Sainz RM, Reiter RJ. Melatonin: a hormone, a tissue factor, an autacoid, as paracoid, and an antioxidant vitamin. J Pineal Res 2003; 34: 75-78.
35. Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F: Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci 1994; 5: 271-276.
36. Poegeller B, Reiter RJ, Tan D-X, Chen L-D, Manchester LC. Melatonin, hydroxyl-radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res 1993; 14: 151-168.
37. Reiter R. Melatonin: clinical relevance. Best Practice & Res Endocr Metab 2003; 17: 773-285.
38. Konturek PC, Konturek SJ, Brzozowski T, Dembinski A, Mytar B, Hahn EG. Gastroprotective activity of melatonin and its precursor, L-tryptophan, against stress-induced and ischemia-induced lesions is mediated by scavenge of oxygen radicals. Scand J Gastroenterol 1997; 32: 433-438.
39. Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA. Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 2006; 1757, 573-589.
40. Konturek PC, Konturek SJ, Majka J, Hahn EG. Melatonin affords protection against gastric lesions induced by ischemia-reperfusion possibly due to its antioxidant and mucosal microcirculatory effects. Europ J Pharmacol 1994; 322: 73-77.
41. Hardeland R, Pandi-Perumal SR. Melatonin, a potent agent in antioxidative defense: Actions as a natural food constituent, gastrointestinal factor, drug and prodrug. Nutr Metab(Lond) 2005; Sep. 10: 2:22.
42. Poegeller B, Reiter RJ, Tan D-X, Chen L-D, Manchester LC. Melatonin, hydroxyl-radical mediated oxidative damage, and aging: a hypothesis. J Pineal Res 1993; 14: 151-168.
43. Maestroni GJM. Immunoneuroendocrine role of melatonin. J Pineal Res 1993. 4: 1-10.
44. Yanagisawa M, Kachi T. Effects of pineal hormone on the Payer's patches in the small intestine. Acta Anat Nippon 1993; 69: 522-527.
45. Czesnikiewicz-Guzik M, Konturek SJ, Loster B, Wisniewska S, Majewski S. Melatonin and its role in oxidative stress related diseases of oral cavity. J Physiol Pharmacol 2007; 58: Suppl. 3: 5-19.
46. Konturek SJ, Zayachkivska O, Havryluk SO et al. Protective influence of melatonin against acute esophageal lesions involves prostaglandins, nitric oxide and sensory nerves. J Physiol Pharmacol 2007; 58: 361-377.
47. de Souza Pereira R. Regression of gastroduodenal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with omeprazole. J Pineal Res 2006; 41: 195-200.
48. Konturek SJ, Konturek PC, Pawlik T, Sliwowski Z, Hahn EG. Dudodenal mucosal protection by bicarbonate secretion and its mechanisms. J Physiol Pharmacol 2004; 55: Suppl. 2: 5-17.
49. Jaworek J, Brzozowski T, Konturek SJ. Melatonin as an organoprotector in the stomach and the pancreas. J Pineal Res 2005; 38: 73-83.
50. Brzozowska I, Konturek PC, Brzozowski T et al. Role of prostaglandins, nitric oxide, sensory nerves and gastrin in acceleration of ulcer healing by melatonin and its precursor, L-tryptophan. J Pineal Res 2002; 32: 149-162.
51. Brzozowski T, Konturek SJ, Pajdo R et al.. The role of melatonin and L-tryptophan in prevetion of gastric lesions induced by stress, ethanol, ischemia and aspirin. J Pineal Res 1997; 23: 79-89.
52. Konturek PC, Konturek SJ, Burnat G, Brzozowski T, Brzozowska I, Reiter R. Dynamic physiological and molecular changes in gastric ulcer healing achieved by melatonin and its precursor L-tryptophan in rats. J Pineal Res 2008; in press
53. Terry PD, Villinger F, Bubenik GA, Sitaraman SV. Melatonin and ulcerative colitis. Evidence, potential mechanisms, and future research. J Pineal Res 2008; in press.
54. Schenhammer ES, Schulmeister K. Melatonin and cancer risk: does light at night compromise physiological cancer protection by lowering serum melatoin levels. Br J Cancer 2004; 90: 941-943.
55. Mills E, Wu P, Seely D, Guyatt G. Melatonin in the treatment of cancer: a systematic review of randomized controlled trias and meta-analysis. J Pineal Res 2005. 39: 360-366.
56. Vician M, Zeman N, Herichova I, Blazicek P, Matis P. Melatonin content in plasma and large intestine in patients with colorectal carcinoma before and after surgery. J Pineal Res 1999; 29: 56-63.
57. Lissoni P, Brivio F, Brivio O et al. Immune effect of preoperative immunotherapy with high dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tumour patients. J Biol Regulators Homeostat Agents 1995; 9: 31-33.
58. Anisimov V, Popovich I, Shtylik A et al. Melatonin and colon carcinogenesis. III. Effects of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dymethylhydrazine in rats. Exp Tox Pathol 2000; 52: 71-76.
59. Wenzel U, Nickel A, Daniel H. Melatonin potentiates flavone-induced apoptosis in human colon cells by increasing the levels of glycolic end producs. Int J Cancer 2005; 116: 236-242.
60. Bartsch C, Kvetnoy I, Kvetnaia T et al. Nocturnal urinary 6-sulfatoxymelatonin and proliferating cell nuclear antigen-immunopositive tumor cells show strong positive correlations in patients with gastrointestinal and lung cancer. J Pineal Res 1997; 90-96.
61. Hardeland R, Poegeller B. Minireview: Non-vertebrate melatonin. J Pineal Res 2003; 34: 233-241.
62. Caniato R, Filippini, Piovan A, Puricelli R, Borsarini A, Cappelletti EM. Melatonin in plants. Adv Exp Med Biol 2003: 527: 503-597.
63. Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Poegeller B, Hardeland R. Melatonin, nature's most versatile biological signal? FEBS J 2006; 273: 2813-2838.
64. Bubenik GA, Pang SF. Melatonin levels in the gastrointestinal tisues of fish, amphibians and a reptile. Gen Comp Endocrinol 1997; 106: 415-419.
65. Bubenik GA, Pang SF. The role of serotonin and melatonin in gastrointestinal physiology: Ontogeny, regulation of food intake and mutual 5-HT , melatonin feedback. J Pineal Res 1994; 16: 91-99.
66. Bubenik GA, Brown GM, Hacker RR, Bartos L. Melatonin levels in the gastrointestinal tract of fetal bovids. Acta Vet 2000; 69: 177-182.
67. Bubenik GA, Ball, RO, Pang SF. The effect of food deprivation on brain and gastrointestinal tissue levels of tryptophan, serotonin, 5-hydroxyindoleacetic acid, and melatonin. J Pineal Res 1992; 12: 115-128.
68. Huether G. Melatonin synthesis in the gastrointestinal tract and the impact of nutritional factors on circulating melatonin. Ann N Y Acad Sci 1994; 719: 146-158.
69. 1 mRNA in the rat intestine under control and fasting conditions. J Pineal Res 2000; 42: 183-188.
70. Song, Gwee KA, Moochhala SM, Ho K. Melatonin attenuated stress-induced defecation: lesson from rat model of stress induced dysfunction. Neurogastroenterol Motil 2005; 17: 744-747.
71. Bubenik GA, Niles LP, Pang SF, Pentney PJ. Diurnal variation and binding characteristics of melatonin in the mouse brain and gastrointestinal tissues. Comp Biochem Physiol 1993; 104C; 221-224.
72. Bubenik GA, Pang SF, Cockshut J et al. Circadian variation of portal, arterial and venous blood levels of melatonin in pigs and its relationship to food intake and sleep. J Pineal Res 2000; 28: 9-15.
73. Pardridge WM, Mietus LJ. Transport of albumin-bound melatonin through the blood-brain barrier. 1980. J Neurochem 1980; 34: 1761-1763.
74. Bubenik GA, Gastrointestinal melatonin - 30 years of research. In: Exp Endocrinol and Reprod Biol. C Haldar, Singaravel M, Pandi-Peruval SR, Cardinali DP. (eds). Enfield, Sci Publishers,2006, pp 17-34.
75. Bubenik GA. Treatment of gastrointestinal diseases with melatonin. In: Contemporary Perspectives in Clinican Pharamacotherapeutics. K. Kohli, M. Gupta, S. Tejwany (eds). Elsevier, New Delhi, India, 2006, pp 356-365.
76. Bubenik GA. Therapeutic perspectives of gastrointestinal melatonin. In: Melatonin: from Molecules to Therapy. Pandi-Perumal SR. Cardinali DP (eds). N.Y. USA, Nova Sci Publishers Inc., 2007, pp 529-545.
77. Mann S. Melatonin for ulcerative colitis? Am J Gastroenterol 2003; 98: 232-233.
78. Jan JE, Freeman RD. Re: Mann-Melatonin for ulcerative colitis? Am J Gastroenterol 2003; 98: 1446.
79. Jan JE, Donnel ME. Use of melatonin therapy in the treatment of pediatric sleep disorders. J Pineal Res 1996; 21: 193-199.
80. Elsenbruch S. Melatonin: A novel treatment for IBS? Gut 2005; 54; 1353-1354.
81. Klupinska G, Wisniewska-Jarosinska M, Harasiuk A et al. Nocturnal secretion of melatonin in patients with upper digestive tract disorders. J Physiol Pharmacol 2006; 57(Suppl. 5): 41-50.
82. Oparin AG, Oparin AA. Oxidative stress as a couse of development of psychosomatic disorders in students with duodenal ulcers. Therap Arkh 2005; 77: 32-34.
83. Song GH, Leng PH, Gwee KA, Moochhala SM, Ho KY. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomized double blind placebo controlled study. Gut 2005; 54: 1402-1407.
84. Lu W-Z, Ko KY, Moochhala SM, Wong PTH, Gwee AK. Bowel symptoms are related to sleep disturbances in shift nurses. Gut 2000; 47; A40.
85. Bubenik GA. Immunohistological localization of melatonin in the salivary gland of the rat. Adv Biosci 1980; 29: 95-112.
86. Sjoblom M, Flemstrom G. Melatonin in the duodenal lumen is a potent stimulant of mucosal bicarbonate seretion. J Pineal Res 2003; 34: 288-293.
87. Sjoblom M, Flemstrom G. Central nervous stimuli increase duodenal bicarbonate secretion by release of mucosal melatonin. J Clin Invest 2001; 108: 625-633.
88. Leja-Szpak A, Jaworek J, Tomaszewska R et al. Melatonin precursor, Ltryptophan protects the pancreass from the development of acute pancreatitis through the central site action. J Physiol Pharmacol 2004; 55: 339-354.
89. 2 receptor in the modulation of caerulein-induced pancreatitits in rats. J Physiol Pharmacol 2002; 53: 791-804.
90. Nishida S, Sato R, Murai I, Nagakawa S. Effect of pinealectomy on plasma levels of insulin and leptin in type 2 diabetic rats. J Pineal Res 2003; 35; 251-256.
91. Nishida S, Segawa T, Murai I, Nagakawa S. Long-term melatonin administration reduces hyperinsulinemia and improves the altered fatty-acid composition in type 2 diabetic rats via restoration of delta -5 desaturase activity. J Pineal Res 2002; 32: 26-33.
92. Jaworek J, Nawrot K, Konturek SJ, Leja-Szpak TP, Pawlik WW. Melatonin and its precursor, L-tryptophan: influence on pancreatic amylase secretion in vivo and in vitro. J Pineal Res 2004; 36: 155-164.
93. Yaga H, Reiter RJ, Richardson BA. Tryptophan loading increases day time serum melatonin in intact and pinealectomized rats. Life Sci 1993; 52: 1231-1238.
94. Menendez-Pelaez A, Poegeller B, Reiter RJ, Barlow-Walden I, Pablos MI, Tan T-X. Nuclear localization of melatonin in the different mammalian tissues: Immunohistochemical and radioimmunoassay evidence. J Cell Biol 1993; 53: 373-382.
95. Messner M, Huether G, Lorf T, Ramdori G, Schwoerrer H. Presence of melatonin in the human hepatobiliary tract. Life Sci 2001; 69: 543-551.
96. Kopin IJ, Pare CMB, Axelrod J, Weissbach H. The fate of melatonin in animals. J Biol Chem 1961; 236: 3072-3075.
97. Messner M, Harderland R, Rodenback A, Huether G. Tissue retention and subcellular distribution of continuously infused melatonin in rats under near physiological conditions. J Pineal Res 1998; 25: 251-259.
98. Tan D-X, Manchester LC, Reiter RJ QI W, Hanes M, Farley NJ. High physiological levels of melatonin in the bile of mammals. Life Sci 1999; 65: 2523-2529.